acidIdentifiersCAS number 12650-69-0ATC code D06AX09 R01AX06PubChem 446596Chemical dataFormula C26H44O9Mol. mass 500.622 g/molPharmacokinetic dataBioavailability ?Protein binding 97%Metabolism bactroban and thrush ?Half life 20 to 40 minutesExcretion ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes cat.

cause of death in hospitalized patients who have received systemic antibiotic therapy. It bactroban and thrush used as bactroban and thrush topical treatment for MRSA. It may also result in overgrowth of non-susceptible organisms.[edit] SourcesThe original manufacturer's (GlaxoSmithKline) bactroban and thrush is Bactroban. It is used as a treatment for bacterial skin infections, bactroban and thrush example, furuncle, impetigo, open wounds etc. It is suggested, however, that mupirocin not be used for extended periods of time, or indiscriminately, as resistance does develop, and bactroban and thrush if it becomes widespread, destroy mupirocin's value as a bactroban and thrush treatment for bacterial skin infections, for example, furuncle, impetigo, open wounds bactroban and thrush It is used as a treatment for MRSA. It may also result in overgrowth of non-susceptible organisms.[edit] SourcesThe original manufacturer's (GlaxoSmithKline) product is Bactroban. It is also useful in the bactroban and thrush of methicillin-resistant Staphyolococcus aureus (MRSA), which is simply called Mupirocin Ointment.[2] MupirocinFrom Wikipedia, the.

is an antibiotic bactroban and thrush isolated from Pseudomonas fluorescens. It is used as a treatment for bacterial skin infections, for example.